InvestorsHub Logo
Followers 8
Posts 829
Boards Moderated 0
Alias Born 04/27/2015

Re: None

Monday, 09/21/2020 11:29:26 AM

Monday, September 21, 2020 11:29:26 AM

Post# of 426474
"And unfortunately, that oral hearing, you know, met with judges who, you know, didn't seem too receptive to, you know, patents, and we lost." Excerpt of JT's reply to Louise Chen when asked about the oral arguments held at the CAFC. From the guy who chose the original court venue, who was unable to forge a settlement with all generic litigants, who has failed to maximize shareholder value in the two years since R-It results hit. At least he's been able to craft and pass an updated executive share compensation plan.
The company, IMO, needs to cut a deal as an authorized generic supplier in the US, rapidly reply to any EMA list of outstanding issues and hire an IB to seek interest for an acquisition of the company. I'm coming to the conclusion of poster CBB in saying,"John Thero is poison."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News